Compounds > 2,7-diaminomitosene
Page last updated: 2024-10-31

2,7-diaminomitosene and Experimental Mammary Neoplasms

2,7-diaminomitosene has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chirrey, L2
Cummings, J2
Halbert, GW2
Smyth, JF2
Willmott, N1

Other Studies

2 other studies available for 2,7-diaminomitosene and Experimental Mammary Neoplasms

ArticleYear
Conversion of mitomycin C to 2,7-diaminomitosene and 10-decarbamoyl 2,7-diaminomitosene in tumour tissue in vivo.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:4

    Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Half-Life; Mammary Neoplasms, Expe

1995
Determination of mitomycin C, 2,7-diaminomitosene, 1,2-cis- and 1,2-trans-1-hydroxy-2,7-diaminomitosene in tumour tissue by high-performance liquid chromatography.
    Journal of chromatography, 1993, Jan-29, Volume: 612, Issue:1

    Topics: Animals; Chromatography, High Pressure Liquid; Female; Hydrogen-Ion Concentration; Mammary Neoplasms

1993